EyeNetra

EyeNetra raises $4M for smartphone vision test to detect easily treated eye problems

An MIT mobile health spinoff wants to bring vision tests to smartphones and has raised $4 million as part of a Series A round. In a phone interview with MedCity News, EyeNetra COO and co-founder David Schafran confirmed the fundraise but was fairly tight-lipped about details such as how the tests would be delivered and […]

By Stephanie Baum

Devices & Diagnostics

Fundraising: Startup that turns mobile phone to eye exam device raises $1M (video)

EyeNetra is developing a device that attaches to a mobile phone and can detect myopia, astigmatism and other eye conditions.

By Arundhati Parmar

Sponsored Post

Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options

FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.

By FASENRA, Sponsored Content

Sponsored Post

Tackling Rising Drug Costs and Growing Popularity of GLP-1’s

See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.

By Quantum Health and MedCity News

Sponsored Post

Changes in Nurse Staffing Answer Clinician Demands

The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.

By Tomasz Rezik

Sponsored Post

Consultants: Help Define What’s Next In Healthcare Benefits

Help shape the future of healthcare benefits by sharing your insights.

By MedCity News